Addressing the Women’s Health Span Paradox

The journey through women's health is often characterized by paradoxes. One such paradox is the Health Span Paradox: women live longer than men but face more significant health challenges, spending a considerable portion of their lives with debilitating conditions. This paradox highlights the need for a more nuanced approach to women’s health, one that Kemin is actively addressing through our innovative ingredient solutions.

Diseases like macular degeneration, dementia, and cardiovascular disease disproportionately affect women.¹ Despite this, these conditions are often underdiagnosed in women, leading to inadequate treatment and care. Cardiovascular disease, for example, -is the leading cause of death in women but remains underdiagnosed due to differing symptoms. This underdiagnosis contributes to the higher morbidity and mortality rates observed in women.^2-3

The current supplement market predominantly addresses maternal and gynecological concerns, which represent only 5% of the global health burden.¹ By overlooking broader health issues that affect women, the industry misses valuable opportunities to improve women's quality of life. Kemin’s ingredients aim to bridge this gap, offering solutions that cater to the broader health needs of women.

Our commitment is driven by a deep curiosity about the health issues women face. We strive to ensure that our ingredient solutions are not only innovative but also relevant to the real challenges women encounter.

We invite supplement manufacturers to partner with us in this mission. Together, we can create products that truly enhance women’s health and well-being at every stage of life.

Join us for part three of our series – the Scientific Paradox. Discover Kemin's innovative portfolio of ingredients for women's health by visiting kemin.com.

Resources

Subscribe to our Blog

These statements have not been evaluated by the US Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

The information on this webpage is a business-to-business information and not intended for the final consumer. Certain statements may not be applicable in all geographical regions. Product labeling and associated claims differs based upon government requirements and country or region specific information should also be considered when labeling or advertising to final consumers.

This web page and its associated brochures and other documents do not constitute or provide scientific or medical advice, diagnosis, or treatment and are distributed without warranty of any kind, either expressly or implied. This web page, its title or contents and associated brochures and other documents do not in any way make recommendations for health or marketing claims by the reader. Country and region specific regulations should be considered in this regard. Each claim or statement about the effectiveness of Kemin products and/or each claim or statement comparing the effectiveness of Kemin products to the effectiveness of other products is expressly limited to the United States, unless otherwise disclosed on the Kemin websites.

References:

1. World Economic Forum. (2024, January). Closing the women’s health gap: A $1 Trillion Opportunity to Improve Lives and Economies. https://www3.weforum.org/docs/WEF_Closing_the_Women’s_Health_Gap_2024.pdf
2. Hammond, B. R., & Renzi-Hammond, L. (2023). The influence of the macular carotenoids on women’s eye and brain health. Nutritional Neuroscience,26(8), 720–726. https://doi.org/10.1080/1028415X.2022.2084125
3. Keteepe-Arachi, T., & Sharma, S. (2017). Cardiovascular Disease in Women: Understanding Symptoms and Risk Factors. European cardiology, 12(1), 10–13. https://doi.org/10.15420/ecr.2016:32:1
4. Study: Across diseases, women are diagnosed later than men. Novo Nordisk Foundation Center for Protein Research. (2020b, July 15). https://www.cpr.ku.dk/cpr-news/2019/study-across-diseases-women-are-diagnosed-later-than-men/